Trial · NCT00534495
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double Blind Placebo Phase Week 0-4 | STARTED | Rilonacept | 36 | |
| Double Blind Placebo Phase Week 0-4 | STARTED | Placebo | 35 | |
| Double Blind Placebo Phase Week 0-4 | STARTED | Long Term Extension All Participants | 0 | |
| Double Blind Placebo Phase Week 0-4 | COMPLETED | Rilonacept | 36 | |
| Double Blind Placebo Phase Week 0-4 | COMPLETED | Placebo | 34 | |
| Double Blind Placebo Phase Week 0-4 | COMPLETED | Long Term Extension All Participants | 0 | |
| Double Blind Placebo Phase Week 0-4 | NOT COMPLETED | Rilonacept | 0 | |
| Double Blind Placebo Phase Week 0-4 | NOT COMPLETED | Placebo | 1 | |
| Double Blind Placebo Phase Week 0-4 | NOT COMPLETED | Long Term Extension All Participants | 0 | |
| All Active Treatment Phase Week 4-24 | STARTED | Rilonacept | 36 | |
| All Active Treatment Phase Week 4-24 | STARTED | Placebo | 34 | |
| All Active Treatment Phase Week 4-24 | STARTED | Long Term Extension All Participants | 0 | |
| All Active Treatment Phase Week 4-24 | COMPLETED | Rilonacept | 32 | |
| All Active Treatment Phase Week 4-24 | COMPLETED | Placebo | 25 | |
| All Active Treatment Phase Week 4-24 | COMPLETED | Long Term Extension All Participants | 0 | |
| All Active Treatment Phase Week 4-24 | NOT COMPLETED | Rilonacept | 4 | |
| All Active Treatment Phase Week 4-24 | NOT COMPLETED | Placebo | 9 | |
| All Active Treatment Phase Week 4-24 | NOT COMPLETED | Long Term Extension All Participants | 0 | |
| Long Term Ext. Phase Week 24-month 21 | STARTED | Rilonacept | 0 | |
| Long Term Ext. Phase Week 24-month 21 | STARTED | Placebo | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00534495/flow